These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31161456)

  • 21. [Are the two formulas of Levothyrox bioequivalent?].
    Coste J; Bertagna X; Zureik M; Nicolas P; Ramez P; Hill C; Schlumberger M
    Rev Prat; 2019 Oct; 69(8):831-837. PubMed ID: 32237644
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lévothyrox
    Wémeau JL; Ladsous M
    Presse Med; 2017 Oct; 46(10):887-889. PubMed ID: 29108724
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply.
    Bertani L; Pugliese D; Tricò D; Costa F; Blandizzi C
    Aliment Pharmacol Ther; 2021 Jan; 53(2):348-349. PubMed ID: 33368507
    [No Abstract]   [Full Text] [Related]  

  • 24. [Both formulas of Levothyrox are not bioequivalent].
    Hill C; Schlumberger M
    Rev Prat; 2019 Jun; 69(6):599-601. PubMed ID: 31626414
    [No Abstract]   [Full Text] [Related]  

  • 25. Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2020 Jan; 59(1):1-5. PubMed ID: 31432471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Authors' Reply: Statins and thyroid-stimulating hormone.
    Leese G
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):747-8. PubMed ID: 25711238
    [No Abstract]   [Full Text] [Related]  

  • 27. Of rats and men: thyroid homeostasis in rodents and human beings - Authors' reply.
    McAninch EA; Bianco AC
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):933. PubMed ID: 26590685
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical trial of Levothyrox 50 in the treatment of hypothyroidism].
    Ben Khalifa F; Ben Abdallah N; Sellami S; el Ach K; Jedidi S; Ben Ayed H
    Tunis Med; 1985; 63(8-9):449-53. PubMed ID: 3911524
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of the "French Levothyrox crisis" on signal detection in the World Health Organization pharmacovigilance database.
    Khouri C; Revol B; Lepelley M; Mallaret M; Cracowski JL
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1427-1428. PubMed ID: 30379373
    [No Abstract]   [Full Text] [Related]  

  • 30. [Levothyrox: a textbook case of the disregard for the patients' words].
    Deleuze J; Tenaillon A
    Rev Prat; 2019 Jun; 69(6):583. PubMed ID: 31626410
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel thyroxine formulations: a further step toward precision medicine.
    Virili C; Trimboli P; Centanni M
    Endocrine; 2019 Oct; 66(1):87-94. PubMed ID: 31617168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reply from Authors re: Jean-Nicolas Cornu, Stephan Madersbacher. Greenlight Photovaporisation of the Prostate: Now Ready for Prime Time. Eur Urol 2016;69:103-4.
    Thomas JA; Bachmann A
    Eur Urol; 2016 Jan; 69(1):105-6. PubMed ID: 26433569
    [No Abstract]   [Full Text] [Related]  

  • 34. Authors' response to "Harder than just hitting a bulls-eye: treatment for hypothyroidism in children might have more than just one target".
    Cannavò L; Aversa T; Corica D; Pepe G; Pajno GB; Alibrandi A; Wasniewska M
    Endocrine; 2020 Jul; 69(1):231-232. PubMed ID: 32323092
    [No Abstract]   [Full Text] [Related]  

  • 35. L-thyroxine therapy and growth processes in children with Down syndrome.
    Kowalczyk K; Pukajło K; Malczewska A; Król-Chwastek A; Barg E
    Adv Clin Exp Med; 2013; 22(1):85-92. PubMed ID: 23468266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.
    Meinel AB; Meinel MP
    Appl Opt; 1985 Apr; 24(7):944. PubMed ID: 20436652
    [No Abstract]   [Full Text] [Related]  

  • 38. Ultrahigh-performance liquid chromatography-ultraviolet absorbance detection-high-resolution-mass spectrometry combined with automated data processing for studying the kinetics of oxidative thermal degradation of thyroxine in the solid state.
    Neu V; Bielow C; Reinert K; Huber CG
    J Chromatogr A; 2014 Dec; 1371():196-203. PubMed ID: 25456598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of two L-thyroxine formulations after oral administration to healthy dogs.
    Simpson C; Devi JL; Whittem T
    Aust Vet J; 2013 Mar; 91(3):83-8. PubMed ID: 23438458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.
    Choolani M; Biswas A
    Singapore Med J; 2013 Apr; 54(4):238. PubMed ID: 23624457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.